Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
More details about Johnson & Johnson’s marketing of controversial transvaginal mesh implants without FDA clearance may prove problematic for the healthcare giant as it seeks to defend against a slew of patient injury lawsuits, but the company maintains that it acted in good faith and that new reports are misleading.
Southern Europe remains a "challenging" environment for ortho giant Stryker as hospitals in Spain and Portugal cut back on procedures in the wake of a crippling recession.
Venture capitalists are no longer looking for a safe bet – they’re on the hunt for disrupters. Managing directors from venture capital firms tell MassDevice where they’re looking to place their limited resources and why the old "play-it-safe" model was broken.